Earnings History Data for Design Therapeutics, Inc. (DSGN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Design Therapeutics, Inc.

Design Therapeutics Inc. is a biotechnology company. It involved in developing a platform of gene targeted chimera small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions. Design Therapeutics Inc. is based in CARLSBAD, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
19-03-2024	AH		DSGN	Design Therapeutics, Inc.	144.49	-0.21	0.00	-0.31	Design Therapeutics GAAP EPS of -$0.21 beats by $0.11 [3/19/2024 4:07 PM]	2.90	0.31 (11.78%)	2.54	-0.05 (-1.92%)	1.94 - 8.47	383,534	160,000	1,756
Design Therapeutics GAAP EPS of -$0.21 beats by $0.11 [3/19/2024 4:07 PM]
13-11-2023	PM		DSGN	Design Therapeutics	111.00	-0.28	-0.42	0.00	Design Therapeutics GAAP EPS of -$0.28 beats by $0.14 [11/14/2023 2:28 AM]	2.29	0.24 (11.71%)	2.12	0.07 (3.41%)	1.94 - 16.38	1,445,678	320,000	300
Design Therapeutics GAAP EPS of -$0.28 beats by $0.14 [11/14/2023 2:28 AM]
14-03-2023	AH		DSGN	Design Therapeutics	363.00	-0.31	-0.34	0.00	Design Therapeutics GAAP EPS of -$0.31 beats by $0.03 [3/14/2023 4:55 PM]	7.02	-0.05 (-0.71%)	7.07	0.0 (0.00%)	6.08 - 26.30	484,578	460,000	10,810
Design Therapeutics GAAP EPS of -$0.31 beats by $0.03 [3/14/2023 4:55 PM]
03-11-2022	AH	4:05 PM ET (Nov 3)	DSGN	Design Therapeutics	847.00	-0.32	-0.28	0.00	Design Therapeutics GAAP EPS of -$0.32 misses by $0.04 [11/3/2022 5:38 PM]	15.46	-0.03 (-0.19%)	15.49	0.0 (0.00%)	9.61 - 26.30	301,850	280,000	5,717
Design Therapeutics GAAP EPS of -$0.32 misses by $0.04 [11/3/2022 5:38 PM] Design Therapeutics Highlights Pipeline Progress and Upcoming Milestones and Reports Third Quarter 2022 Financial Results [Nov-03-22 04:05PM]
10-03-2022	AH		DSGN	Design Therapeutics	893.00	-0.20	-0.22	0.00	Design Therapeutics GAAP EPS of -$0.20 [3/10/2022 5:27 PM]	17.30	-0.27 (-1.54%)	17.57	0.0 (0.00%)	10.37 - 50.50	65,644	150,000	632
Design Therapeutics GAAP EPS of -$0.20 [3/10/2022 5:27 PM] Design Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results [Mar-10-22 04:02PM] Design Therapeutics Announces Preclinical Data Highlighting Novel GeneTAC Therapy for the Treatment of Fuchs Endothelial Corneal Dystrophy to be Presented at ARVO 2022 [Mar-09-22 06:30AM]
09-11-2021	AH	4:05 PM ET (Nov 9)	DSGN	Design Therapeutics, Inc.	978.29	-0.21	-0.14	0.00	Design Therapeutics EPS misses by $0.07 [11/9/2021 5:04 PM]	18.88	-0.03 (-0.19%)	18.91	0.0 (0.00%)	12.52 - 50.50	118,985	120,000	178
Design Therapeutics EPS misses by $0.07 [11/9/2021 5:04 PM] Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results [Nov-09-21 04:05PM]